Grant of Options

RNS Number : 9500T
Allergy Therapeutics PLC
19 December 2012
 



19 December 2012

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

 

Grant of Options

 

Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 19 December 2012 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:

 

Director

Number of provisional shares awarded

Date of distribution

Total provisional shares held under LTIPs

Manuel Llobet

720,000

19 December 2012

2,160,000

Ian Postlethwaite

360,000

19 December 2012

1,080,000

 

 

The issuance and distribution of ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the three years ending 30 June 2015.

 

-Ends-

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer




Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBUBDDDBBBGDC
UK 100

Latest directors dealings